Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations.

Camara-Lemarroy, Carlos R;Gonzalez-Moreno, Emmanuel I;Ortiz-Corona, Jose de Jesus;Yeverino-Castro, Sara G;Galarza-Delgado, Dionicio A;et.al.
(2014) Journal of Clinical Endocrinology and Metabolism —

Files

No attached file found for this publication.

Details

Authors
  • Camara-Lemarroy, Carlos R
    Author
  • Gonzalez-Moreno, Emmanuel I
    Author
  • Ortiz-Corona, Jose de Jesus
    Author
  • Yeverino-Castro, Sara G
    Author
  • Galarza-Delgado, Dionicio A
    Author
Show more
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a neurological entity characterized by seizures, headache, and reversible subcortical vasogenic edema. It is associated with many etiologies, most often hypertension, chronic renal failure, and chemotherapy. Hypercalcemia is rarely associated with PRES.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Camara-Lemarroy, C. R., Gonzalez-Moreno, E. I., Ortiz-Corona, J. d. J., Yeverino-Castro, S. G., Sanchez-Cardenas, M., Nuñez-Aguirre, S., Villarreal-Alarcon, M. A., & Galarza-Delgado, D. A. (2014). Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations. Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/jc.2013-3487